AI in Drug Discovery
A significant shift is underway in the approach to drug discovery, moving from repurposing legacy data to designing experiments tailored for machine learning. This cultural transformation challenges traditional scientific intuition, as algorithms may suggest counterintuitive combinations. The potential of generative AI, particularly in understanding proteins as a language, offers exciting possibilities for new drug modalities, including targeted protein degradation.In this clip
From this podcast
Raising Health
Adapting Biopharma to AI with Greg Meyers
Related Questions